First Republic Executives Fail in Attempt to Recover Nonqualified Deferred Compensation Plan Assets
Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's EnbrelĀ® TNF inhibitor. Specifically, EnbrelĀ® is a...more